(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 9244.20 | 8048.30 | 14.86 | 9244.20 | 8048.30 | 14.86 | 37902.00 | 37234.90 | 1.79 |
| Other Income | 616.30 | 437.60 | 40.84 | 616.30 | 437.60 | 40.84 | 1425.60 | 1425.60 | 0.00 |
| PBIDT | 3547.90 | 2945.10 | 20.47 | 3547.90 | 2945.10 | 20.47 | 14427.60 | 13118.50 | 9.98 |
| Interest | 9.70 | 4.20 | 130.95 | 9.70 | 4.20 | 130.95 | 27.30 | 13.10 | 108.40 |
| PBDT | 3538.20 | 2940.90 | 20.31 | 3538.20 | 2940.90 | 20.31 | 14426.70 | 13152.30 | 9.69 |
| Depreciation | 158.40 | 155.20 | 2.06 | 158.40 | 155.20 | 2.06 | 664.40 | 667.90 | -0.52 |
| PBT | 3379.80 | 2785.70 | 21.33 | 3379.80 | 2785.70 | 21.33 | 13762.30 | 12484.40 | 10.24 |
| TAX | 846.50 | 738.70 | 14.59 | 846.50 | 738.70 | 14.59 | 3644.10 | 3293.80 | 10.64 |
| Deferred Tax | 33.00 | 0.20 | 16400.00 | 33.00 | 0.20 | 16400.00 | 94.60 | 62.00 | 52.58 |
| PAT | 2533.30 | 2047.00 | 23.76 | 2533.30 | 2047.00 | 23.76 | 10118.20 | 9190.60 | 10.09 |
| Equity | 1694.10 | 1694.10 | 0.00 | 1694.10 | 1694.10 | 0.00 | 1694.10 | 1694.10 | 0.00 |
| PBIDTM(%) | 38.38 | 36.59 | 4.88 | 38.38 | 36.59 | 4.88 | 38.07 | 35.23 | 8.04 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1949.00 |
| Dr. Reddys Labs. | 1174.00 |
| Cipla | 1450.00 |
| Lupin | 2386.00 |
| Zydus Lifesciences | 1111.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: